Skip to main content
. 2022 Feb 22;13:816566. doi: 10.3389/fendo.2022.816566

Table 1.

Baseline characteristics.

Prior to randomization (n = 59) Allocated to first LT4 then LT3 (n = 27) Allocated to first LT3 then LT4 (n = 32) P value
Age at inclusion (years) 42.9 ± 9.7 42.8 ± 8.6 42.9 ± 10.7 0.991
Age at hypothyroidism diagnosis (years) 30.6 ± 10.2 29.8 ± 8.6 31.2 ± 11.4 0.590
Duration of substitution monotherapy LT4 (years) 10.6 ± 7.0 10.9 ± 7.3 10.3 ± 6.8 0.778
Type of therapy at inclusion
 LT4 monotherapy 46 (78.0) 20 (74.1) 26 (81.3) 0.513
 LT4/LT3 combination therapy 12 (20.3) 7 (25.9) 5 (15.5) 0.728
 Thyroid extract 1 (1.7) 0 (0) 1 (3.1) 1.000
Etiology of hypothyroidism
 Autoimmune/idiopathic 56 (94.9) 27 (100%) 29 (90.6) 0.299
 Post-surgical 2 (3.4) 0 (0) 2 (6.3) 0.549
 Radioiodine 1 (1.7) 0 (0) 1 (3.1) 1.000
Body mass index (kg/m2) 28.1 ± 5.6 28.5 ± 5.9 27.8 ± 5.5 0.624
Resting heart rate (beats/minute) 64.7 ± 11.2 67.4 ± 12.1 62.4 ± 9.9 0.084
Systolic blood pressure (mmHg) 118.0 ± 13.7 115.5 ± 13.2 120.2 ± 13.9 0.191
Diastolic blood pressure (mmHg) 78.3 ± 7.9 77.2 ± 8.7 79.4 ± 7.0 0.282
TSH (mU/L) 0.64 (0.26-1.60) 0.82 (0.28-1.50) 0.63 (0.25-1.9) 0.767
FT4 (pmol/L) 16.8 (14.7-19.0) 17.0 (14.2-20.0) 16.4 (14.8-18.0) 0.970
FT3 (pmol/L) 4.4 (3.8-4.9) 4.4 (3.8-4.8) 4.4 (3.8-5.0) 0.664
Positive TPO-ab1 31 (52.5) 17 (63.0) 14 (43.8) 0.226
Residual hypothyroid symptoms
 Fatigue 57 (96.6) 26 (96.3) 31 (96.6) 1.000
 Cold-intolerance 54 (91,5) 26 (96.3) 28 (87.5) 0.460
 Cognitive disturbances 48 (81.4) 24 (88.9) 24 (75.0) 0.303
 Emotional disturbances 38 (64.4) 16 (59.3) 22 (68.8) 0.627

Data are presented as mean ± SD or number (%) or median (interquartile range: 25-75%) as appropriate.

TSH, thyroid stimulating hormone; FT4, free thyroxine; FT3, free triiodothyronine; TPO-ab, thyroid peroxidase antibodies. 1Cut-off value for positive TPO-ab was 35 kIU/l.